TY - JOUR
T1 - Ten years of NAD-dependent SIR2 family deacetylases
T2 - Implications for metabolic diseases
AU - Imai, Shin Ichiro
AU - Guarente, Leonard
N1 - Funding Information:
We apologize to those whose work is not cited due to space limitations. We thank members in the Imai research team and the Guarente research team for critical discussions and suggestions. S.I. is supported by grants from the National Institute on Aging (AG024150), Ellison Medical Foundation, and Longer Life Foundation. L.G. is supported by the Glenn Foundation and grants from NIH and the American Asthma Foundation. S.I. and L.G. serve as scientific advisory board members for Sirtris pharmaceuticals, a GSK company.
PY - 2010/5
Y1 - 2010/5
N2 - Since the discovery of NAD-dependent deacetylase activity of the silent information regulator-2 (SIR2) family ('sirtuins'), many exciting connections between protein deacetylation and energy metabolism have been revealed. The importance of sirtuins in the regulation of many fundamental biological responses to various nutritional and environmental stimuli has been firmly established. Sirtuins have also emerged as critical regulators for aging and longevity in model organisms. Their absolute requirement of NAD has revived an enthusiasm in the study of mammalian biosynthesis of NAD. Sirtuin-targeted pharmaceutical and nutriceutical interventions against age-associated diseases are also on the horizon. This review summarizes the recent progress in sirtuin research (particularly in mammalian sirtuin biology) and re-evaluates the connection between sirtuins, metabolism, and age-associated diseases (e.g., type-2 diabetes) to set a basis for the next ten years of sirtuin research.
AB - Since the discovery of NAD-dependent deacetylase activity of the silent information regulator-2 (SIR2) family ('sirtuins'), many exciting connections between protein deacetylation and energy metabolism have been revealed. The importance of sirtuins in the regulation of many fundamental biological responses to various nutritional and environmental stimuli has been firmly established. Sirtuins have also emerged as critical regulators for aging and longevity in model organisms. Their absolute requirement of NAD has revived an enthusiasm in the study of mammalian biosynthesis of NAD. Sirtuin-targeted pharmaceutical and nutriceutical interventions against age-associated diseases are also on the horizon. This review summarizes the recent progress in sirtuin research (particularly in mammalian sirtuin biology) and re-evaluates the connection between sirtuins, metabolism, and age-associated diseases (e.g., type-2 diabetes) to set a basis for the next ten years of sirtuin research.
UR - http://www.scopus.com/inward/record.url?scp=77952547233&partnerID=8YFLogxK
U2 - 10.1016/j.tips.2010.02.003
DO - 10.1016/j.tips.2010.02.003
M3 - Review article
C2 - 20226541
AN - SCOPUS:77952547233
SN - 0165-6147
VL - 31
SP - 212
EP - 220
JO - Trends in Pharmacological Sciences
JF - Trends in Pharmacological Sciences
IS - 5
ER -